Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Study AK1113351, a fixed dose study of 323U66 SR in the treatment of Major Depressive Disorder (MDD) - a multi-center, placebo-controlled, randomized, double-blind, parallel-comparison study
bupropion
AK1113351
NCT01138007
Depressive Disorder
Phase 3
 
A reporting and analysis plan is not available for this study.
October 2015

Powered by ideaPoint, Inc.